A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort

• Yong-Hong Zhang ,

  Contributed equally to this work with: Yong-Hong Zhang, Yan Zhao

  * E-mail: 13810108505@163.com (YHZ); Tao.dong@imm.ox.ac.uk (TD)

  Affiliations You’an-Oxford Centre for Clinical Research, Beijing You’an Hospital, Capital Medical University, Beijing, China, CAMS- Oxford University joint International Centre for Translational Immunology, Nuffield and Radcliffe departments of Medicine, University of Oxford, Oxford, United Kingdom, Beijing Key Laboratory for Biomarkers in Infection Related Diseases (BZ0373), Beijing, China

  ⨯
• Yan Zhao ,

  Contributed equally to this work with: Yong-Hong Zhang, Yan Zhao

  Affiliations You’an-Oxford Centre for Clinical Research, Beijing You’an Hospital, Capital Medical University, Beijing, China, CAMS- Oxford University joint International Centre for Translational Immunology, Nuffield and Radcliffe departments of Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Ushani S. Rajapaksa,

  Affiliations MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom, Department of Microbiology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka

  ⨯
• Tessa M. Lawrence,

  Affiliation Viral Hepatitis Laboratory, Centre for Human Virology, College of Medical and Dental Sciences, University of Birmingham, United Kingdom

  ⨯
• Yan-Chun Peng,

  Affiliation MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Jinghua Liu,

  Affiliation You’an-Oxford Centre for Clinical Research, Beijing You’an Hospital, Capital Medical University, Beijing, China

  ⨯
• Keyi Xu,

  Affiliation Beijing Di’Tan Hospital, Capital Medical University, Beijing, China

  ⨯
• Ke Hu,

  Affiliation Viral Hepatitis Laboratory, Centre for Human Virology, College of Medical and Dental Sciences, University of Birmingham, United Kingdom

  ⨯
• Ling Qin,

  Affiliation You’an-Oxford Centre for Clinical Research, Beijing You’an Hospital, Capital Medical University, Beijing, China

  ⨯
• Ning Liu,

  Affiliation You’an-Oxford Centre for Clinical Research, Beijing You’an Hospital, Capital Medical University, Beijing, China

  ⨯
• Huanqin Sun,

  Affiliation You’an-Oxford Centre for Clinical Research, Beijing You’an Hospital, Capital Medical University, Beijing, China

  ⨯
• Hui-Ping Yan,

  Affiliation You’an-Oxford Centre for Clinical Research, Beijing You’an Hospital, Capital Medical University, Beijing, China

  ⨯
• Emmanouela Repapi,

  Affiliation Computational Biology Research Group, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Sarah Rowland-Jones,

  Affiliation Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Robert Thimme,

  Affiliation University Hospital Freiburg, Department of Medicine II, Hugstetter Str 55, 79106, Freiburg, Germany

  ⨯
• Jane A. McKeating,

  Affiliation Viral Hepatitis Laboratory, Centre for Human Virology, College of Medical and Dental Sciences, University of Birmingham, United Kingdom

  ⨯
•  [ ... ],
• Tao Dong

  * E-mail: 13810108505@163.com (YHZ); Tao.dong@imm.ox.ac.uk (TD)

  Affiliations You’an-Oxford Centre for Clinical Research, Beijing You’an Hospital, Capital Medical University, Beijing, China, CAMS- Oxford University joint International Centre for Translational Immunology, Nuffield and Radcliffe departments of Medicine, University of Oxford, Oxford, United Kingdom, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• [ view all ]
• [ view less ]